FoxLogica

πŸ“‰ FIMM: SELL Signal (8/10) – Financial Results for the Quarter Ended September 30, 2025

⚑ Flash Summary

First Imrooz Modaraba reported a challenging quarter ending September 30, 2025, with a loss of PKR 2.185 million compared to a profit of PKR 29.162 million in the same period last year. Sales decreased from PKR 308.119 million to PKR 252.402 million. The decrease in profitability is attributed to lower sales and higher levies. The company’s cash flow from operating activities also shows a significant decline compared to the previous year, emphasizing the need for strategic adjustments.

Signal: SELL πŸ“‰
Strength: 8/10
Sentiment: NEGATIVE
Time Horizon: SHORT_TERM

πŸ“Œ Key Takeaways

  • πŸ“‰ Net loss of PKR 2.185 million compared to a profit of PKR 29.162 million YoY.
  • πŸ“‰ Sales decreased by 18.08% from PKR 308.119 million to PKR 252.402 million YoY.
  • πŸ’° Operating expenses increased to PKR 32.996 million from PKR 26.193 million YoY.
  • πŸ’Έ Financial charges decreased to PKR 5.703 million from PKR 8.078 million YoY.
  • πŸ“Š Basic and diluted loss/earnings per certificate is PKR -0.73 compared to PKR 9.72 YoY.
  • ⬇️ Cash generated from operating activities decreased from PKR -101.19 million to PKR 12.130 million YoY.
  • liabilities increased from PKR 169.485 million to PKR 25.264 million YoY.
  • ⬆️ Cash generated from investing activities decreased from PKR 15,000 to PKR -9.048 million YoY.
  • ⬆️ Receipts of Qard-e-Hasana from Modaraba Management Company decreased from PKR 133.00 million to PKR 69.00 million YoY.
  • ⬇️ Repayment of Musharaka finances decreased from PKR -438.844 million to PKR -419.978 million YoY.
  • ❌ No dividends were declared for the period.
  • 🏦 Cash and bank balances decreased to PKR 5.918 million from PKR 13.928 million YoY.
  • ⚠️ Company faced significant pressure on profitability and cash flow during the quarter.
  • πŸ€” Decline in sales and increase in levies contributed to the net loss.

🎯 Investment Thesis

Given the negative financial performance, including a net loss and declining revenue, a SELL recommendation is warranted. The price target is PKR 5, with a time horizon of 6 months, based on the expectation of continued market pressures and operational inefficiencies. The company needs to demonstrate significant improvements in profitability and cash flow to justify a more positive outlook. Without substantial changes, the stock is likely to underperform.

View Original PDF

Disclaimer: AI-generated analysis. Not financial advice.

Exit mobile version